Association of Endogenous Hormones with C-reactive Protein, Fibrinogen, and White Blood Count in Post-menopausal Women
- 1 December 2005
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 20 (12) , 1015-1022
- https://doi.org/10.1007/s10654-005-3657-0
Abstract
Oral exogenous estrogen raises C-reactive protein (CRP) concentrations, but the impact of endogenous hormones is unknown. We examined the cross-sectional relation of several serum hormones with CRP, fibrinogen, and white blood cell count – three inflammatory markers linked prospectively to coronary artery disease. Serum hormones were measured on a sample (n=317) of postmenopausal female participants, with or without carotid intima-media thickening, in the Atherosclerosis Risk in Communities (ARIC) Study. Fibrinogen and white blood cell count were available on all and CRP in a subset (n=57). Adjusted for age, race, and case-control status, mean CRP was 2-fold greater in the highest vs. lowest quartiles of estrone and androstenedione, and CRP was 2-fold less across quartiles of sex hormone binding globulin. These associations were not all statistically significant with this sample size. Fibrinogen and white blood cell count also were associated positively with estrone, androstenedione, and testosterone (and fibrinogen also with dehydroepiandrosterone sulfate). Adjustment for other risk factors and especially body mass index, a known determinant of endogenous hormone levels, attenuated most associations. In conclusion, several endogenous sex hormones may influence basal levels of inflammatory markers. Obesity appears to play a modulating role.Keywords
This publication has 49 references indexed in Scilit:
- Increased Levels of C-Reactive Protein After Oral Hormone Replacement Therapy May Not Be Related to an Increased Inflammatory ResponseCirculation, 2003
- The effect of 17β-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trialAtherosclerosis, 2002
- Effect of Oral Postmenopausal Hormone Replacement on Progression of AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Tamoxifen and Cardiac Risk Factors in Healthy WomenArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal WomenArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Effect of Postmenopausal Hormones on Inflammation-Sensitive ProteinsCirculation, 1999
- Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: Methods and initial two years' experiencePublished by Elsevier ,1996
- Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Hormonal Abnormalities in ObesityActa Medica Scandinavica, 1987
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957